Recombinant human prothrombin kringle-2 inhibits B16F10 melanoma metastasis through inhibition of neovascularization and reduction of matrix metalloproteinase expression

Bicknell R, Harris AL (1996) Mechanisms and therapeutic implications of angiogenesis. Curr Opin Oncol 8:60–65

Scott PA, Harris AL (1994) Current approaches to targeting cancer using antiangiogenesis therapies. Cancer Treat Rev 20:393–412

Risau W (1997) Mechanisms of angiogenesis. Nature 386:671–674

Curran S, Murray GI (2000) Matrix metalloproteinases: molecular aspects of their roles in tumor invasion and metastasis. Eur J Cancer 36:1621–1630

Talbot DC, Brown PD (1996) Experimental and clinical studies on the use of matrix metalloproteinase inhibitors for the treatment of cancer. Eur J Cancer 32:2528–2533

Kim TH, Kim E, Yoon D et al (2002) Recombinant human prothrombin kringles have potent anti-angiogenic activities and inhibit Lewis lung carcinoma tumor growth and metastases. Angiogenesis 5:191–201

Lee TH, Rhim T, Kim SS (1998) Prothrombin kringle 2 domain has growth inhibitory activity against bFGF-stimulated capillary endothelial cell. J Biol Chem 273:28805–28812

O’Reilly MS, Holmgren L, Shing Y et al (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79:315–328

Trochon V, Mabilat C, Bertrand P et al (1996) Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro. Int J Cancer 66:644–648

Kang IC, Lee YD, Kim DS (1999) A novel disintegrin salmosin inhibits tumor angiogenesis. Cancer Res 59:3754–3760

Parangi S, O’Reilly M, Christofori G et al (1996) Antiangiogenic therapy of transgenic mice impairs de novo tumor growth. Proc Natl Acad Sci USA 93:2002–2007

Folkman J, Shing Y (1992) Angiogenesis. J Biol Chem 267:10931–10934

Ji WR, Castellino FJ, Chang Y et al (1998) Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis. FASEB J 12:1731–1738

Ji WR, Barrientos LG, Llinas M et al (1998) Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis. Biochem Biophys Res Commun 247:414–419

Hynes RO (1992) Integrins: versatility, modulation and signaling in cell adhesion. Cell 69:11–25

Stupack DG, Cheresh DA (2004) Integrins and angiogenesis. Curr Top Dev Biol 64:207–238

Chess PR, Ryan RM, Finkelstein JN (1994) Tyrosine kinase activity is necessary for growth factor-stimulated rabbit type II pneumocyte proliferation. Pediatr Res 36:481–486

Kikkawa Y, Yoneda K, Smith F et al (1975) The type II epithelial cells of the lung. II. Chemical composition and phospholipids synthesis. Lab Invest 32:295–302

Kaner RJ, Ladetto JV, Singh R et al (2000) Long overexpression of the vascular endothelial growth factor gene induces pulmonary edema. Am J Respir Cell Mol Biol 22:657–664

Curran S, Murray GI (1999) Matrix metalloproteinases in tumour invasion and metastasis. J Pathol 189:300–208

Westermarck J, Kahari VM (1999) Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13 781–792

Ray JM, Stetler-Stevenson WG (1995) Gelatinase A activity directly modulates melanoma cell adhesion and spreading. EMBO J 14:908–917

Fang J, Shing Y, Wiederschain D et al (2000) Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc Natl Acad Sci USA 97:3884–3889

Bergers G, Brekken R, McMahon G et al (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2:737–744

Mullins D, Rohlich ST (1983) The role of proteinase in cellular invasiveness. Biochem Biophys Acta 695:177–214